4 recruiting. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 4 |
| Phase 2 | 2 | Recruiting 2 |
Follow Vitiligo: new trials by email Literature Review of Vitiligo trials Research Report on Vitiligo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo MH004 1.0% Ointment, MH004 Placebo Ointment - Vitiligo | Phase 3 | Recruiting | Minghui Pharmaceutical (Hangzhou) Ltd | 405 | 2026-08-04 | 2026-08-11 |
| Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study. Crisaborole 2% topical ointment, tacrolimus 0.1%, Excimer Light therapy - Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 3 | Recruiting | Cairo University | 35 | 2026-05-15 | 2026-10-29 |
| Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus Ruxolitinib Cream 1.5%, Aqueous cream - Vitiligo | Phase 2 / Phase 3 | Recruiting | Hospital Authority, Hong Kong | 20 | 2024-11-29 | 2024-12-05 |
| Vitiligo, New Treatment and Serum s100B Baricitinib, oral mini pulse, Narrow Band UVB Treatment - Vitiligo, Generalized | Phase 2 / Phase 3 | Recruiting | South Valley University | 50 | 2024-10-02 | 2025-01-10 |
Hypopigmentation (4) · Pigmentation Disorders (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4)
Ointments (2) · baricitinib (1) · crisaborole (1)
Cairo University (1) · Hospital Authority, Hong Kong (1) · Minghui Pharmaceutical (Hangzhou) Ltd (1) · South Valley University (1)
Egypt (2) · China (1) · Hong Kong (1)
YM Lau (1)